Journal: Chemotherapy
Submission Deadline: September 30, 2024
The article collection “Therapeutic Drug Monitoring in the Cancer Patient” is intended as a forum for research or review articles on various aspects of Therapeutic Drug Monitoring (TDM) in contemporary oncology, including studies of small molecules (cytostatic/cytotoxics, tyrosine kinase inhibitors, immunomodulators), antibodies, and CAR-T cells. Screening for drug metabolism polymorphism and pharmacokinetic correlates of drug efficacy or toxicity in special populations - children, the elderly, high-risk multi-morbidity patients - would be important topics to address.
Authors should refer to the author guidelines. The manuscript submission deadline is September 30, 2024.
Please select the option “Call for Papers: Therapeutic Drug Monitoring in the Cancer Patient” when submitting your manuscript and mention this Call for Papers in your cover letter.
Chemotherapy supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.